MENU
+Compare
IMCC
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$1.97
Change
-$0.08 (-3.90%)
Capitalization
10.34M

IMCC IM Cannabis Corp. Forecast, Technical & Fundamental Analysis

IM Cannabis Corp is a Canada-based international medical cannabis company... Show more

IMCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IMCC with price predictions
Sep 05, 2025

Momentum Indicator for IMCC turns negative, indicating new downward trend

IMCC saw its Momentum Indicator move below the 0 level on August 20, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned negative. In of the 86 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

IMCC moved below its 50-day moving average on August 12, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IMCC crossed bearishly below the 50-day moving average on August 01, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMCC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IMCC entered a downward trend on August 29, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMCC advanced for three days, in of 204 cases, the price rose further within the following month. The odds of a continued upward trend are .

IMCC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.049) is normal, around the industry mean (16.695). P/E Ratio (0.000) is within average values for comparable stocks, (74.248). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.899). IMCC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (0.149) is also within normal values, averaging (42.937).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IMCC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMCC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
IMCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Central District
Phone
+972 544331111
Employees
153
Web
https://www.imcannabis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPN87.780.50
+0.57%
Global Payments
UCAR2.04N/A
+0.23%
U Power Limited
CAKE60.63-0.45
-0.74%
Cheesecake Factory
SERA3.34-0.07
-2.05%
Sera Prognostics
DNA11.15-0.53
-4.54%
Ginkgo Bioworks Holdings

IMCC and Stocks

Correlation & Price change

A.I.dvisor tells us that IMCC and CRON have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMCC and CRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCC
1D Price
Change %
IMCC100%
-3.90%
CRON - IMCC
25%
Poorly correlated
N/A
SHIEF - IMCC
25%
Poorly correlated
N/A
DVAX - IMCC
23%
Poorly correlated
+0.80%
SCYX - IMCC
22%
Poorly correlated
+2.43%
SNDL - IMCC
22%
Poorly correlated
+1.64%
More

Groups containing IMCC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCC
1D Price
Change %
IMCC100%
-3.90%
Pharmaceuticals: Generic
industry (222 stocks)
-7%
Poorly correlated
+2.50%